Evidence map›Paper›PMID 37310297›Full record

ArticleMicrobiology resource announcements2023

Complete Coding Sequence of a Lineage AY.122 SARS-CoV-2 Virus Strain Detected in Kazakhstan.

Bekbolat Usserbayev, Yergali Abduraimov, Nurlan Kozhabergenov, Aibarys Melisbek, Meirzhan Shirinbekov, Manar Smagul, Gaukhar Nusupbaуeva, Aziz Nakhanov, Yerbol Burashev

Open access · diamondAbstract read
In one paragraph

Article in Microbiology resource announcements, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bekbolat UsserbayevResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Yergali AbduraimovResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Nurlan KozhabergenovResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Aibarys MelisbekResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Meirzhan ShirinbekovResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Manar SmagulScientific and Practical Center for Sanitary and Epidemiological Expertise and Monitoring Branch of the Republican State Enterprise on the Right of Economic Use, National Center for Public Health of the Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan.
Gaukhar NusupbaуevaScientific and Practical Center for Sanitary and Epidemiological Expertise and Monitoring Branch of the Republican State Enterprise on the Right of Economic Use, National Center for Public Health of the Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan.
Aziz NakhanovResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.
Yerbol BurashevResearch Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan.ORCID 0000-0002-4701-1992
Ministry of Health of the Republic of Kazakhstan · KZAl-Farabi Kazakh National University · KZ

Funding

Ministry of Education and Science of the Republic of Kazakhstan (Ministry of Education and Science, Republic of Kazakhstan) AP09058338
6 · The paper itself

Abstract

We describe the coding-complete genome sequence of a strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) obtained from a patient with symptoms of coronavirus disease 2019 (COVID-19), detected in the Republic of Kazakhstan. According to the Pangolin COVID-19 database, the studied strain, SARS-CoV-2/Human/KAZ/Delta-020/2021, belongs to lineage AY.122 and consists of 29,840 nucleotides.

Identifiers

PMID37310297
PMCPMC10353410
OpenAlexW4380421872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.